Skip to content
EmergingResearch compoundReference only

Nooglutyl

Experimental Russian nootropic that strengthens the brain's excitatory signalling; data are mostly from animal studies.

NootropicAmpakineAmpakineGlutamateGlutamateAMPA
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassAmpakine · Glutamate
Primary targetAMPA glutamate receptor positive allosteric modulator
Targets3 receptor targets
EvidenceReference only
Affected systemsGlutamateAMPA

Contents

DETAILED OVERVIEW

What is Nooglutyl?

Nooglutyl is an experimental compound that comes from an institute of the Russian Academy of Sciences. It is not an approved medicine anywhere and is rarely sold in the West, where it appears as a research chemical. There are no studies in humans, only early results, mostly from animal studies.

It boosts excitatory signalling in the brain. In animal studies it reduced the anxiety that follows withdrawal from sedatives, preserved the cells' energy production after an injury, and improved thinking performance in animals with accelerated ageing. Its safety profile rests mainly on animal studies and user reports, and the long-term effects are unknown; the reports mention restlessness, anxiety and sleep problems. In epilepsy or a low seizure threshold it could in theory raise the risk of seizures, and in anxiety disorders it may worsen symptoms. There are no safety data for pregnancy or breastfeeding.

Mechanism

AMPA-PAM (glutamatergic)

Half-life

No published human data

Legal status

Russian preclinical only

Receptor profile

  • AMPA glutamate receptorsStrong
  • Synaptic plasticity / LTPModerate
  • Antiamnesic / antihypoxic pathwaysModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Limited human safety data: profile based mainly on animal studies and anecdotes
  • Mild anxiety and restlessness reported anecdotally (glutamatergic/stimulating character)
  • Physical stimulation and overstimulation at higher doses (above ~20 mg)
  • Theoretical risk typical of AMPA-enhancing compounds: headache, increased neuronal excitability
  • Sleep disturbance and difficulty falling asleep if taken in late afternoon or evening
  • Long-term safety unknown; chronic adverse effects not characterized

Contraindications · 5

  • Pregnancy and breastfeeding: no safety data, avoid
  • Epilepsy or low seizure threshold: AMPA/glutamatergic enhancement may theoretically raise seizure risk
  • Anxiety disorders: the stimulating character may worsen symptoms
  • Combining with other glutamatergic or stimulant nootropics requires caution (additive overstimulation)
  • Not an approved drug, no human dosing standard; research chemical only, use is experimental

Related Nootropics

Same therapeutic category

FAQ

FAQ

Nooglutyl is an experimental compound developed at a Russian research institute that strengthens one of the brain's excitatory signaling systems (the AMPA receptor), so it's studied as a plasticity enhancer, meaning something meant to support the brain's ability to learn and adapt. Based on the source, this is a purely research-stage, experimental substance with no broad, reliable human data available. In practice it's a lab compound, not an established, well-tested supplement.

Telegram

Have a question about Nooglutyl?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC11H12N2O6
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.